Gang Cao

UGenix Biotech Ltd. is a holding company, which engages in the provision of prenatal testing, precision oncology, and pathogenic detection services. The company was founded on October 26, 2021 and is headquartered in Hong Kong.

Beijing Saimo Technology Co., Ltd. engages in the design, research, and development of ICV Simulation testing products; and in the provision of related testing, validation, and evaluation solutions. Its business activities include testing, evaluation, and verification of the functionality, compatibility, safety, reliability, and comfortability of autonomous driving vehicles in the China. The company was founded on January 24, 2014 and is headquartered in Beijing, China.

Beijing Saimo Technology Co., Ltd. engages in the design, research, and development of ICV Simulation testing products; and in the provision of related testing, validation, and evaluation solutions. Its business activities include testing, evaluation, and verification of the functionality, compatibility, safety, reliability, and comfortability of autonomous driving vehicles in the China. The company was founded on January 24, 2014 and is headquartered in Beijing, China.

Beijing Saimo Technology Co., Ltd. engages in the design, research, and development of ICV Simulation testing products; and in the provision of related testing, validation, and evaluation solutions. Its business activities include testing, evaluation, and verification of the functionality, compatibility, safety, reliability, and comfortability of autonomous driving vehicles in the China. The company was founded on January 24, 2014 and is headquartered in Beijing, China.

Beijing Saimo Technology Co., Ltd. engages in the design, research, and development of ICV Simulation testing products; and in the provision of related testing, validation, and evaluation solutions. Its business activities include testing, evaluation, and verification of the functionality, compatibility, safety, reliability, and comfortability of autonomous driving vehicles in the China. The company was founded on January 24, 2014 and is headquartered in Beijing, China.

Beijing Saimo Technology Co., Ltd. engages in the design, research, and development of ICV Simulation testing products; and in the provision of related testing, validation, and evaluation solutions. Its business activities include testing, evaluation, and verification of the functionality, compatibility, safety, reliability, and comfortability of autonomous driving vehicles in the China. The company was founded on January 24, 2014 and is headquartered in Beijing, China.

UGenix Biotech Ltd. is a holding company, which engages in the provision of prenatal testing, precision oncology, and pathogenic detection services. The company was founded on October 26, 2021 and is headquartered in Hong Kong.

UGenix Biotech Ltd. is a holding company, which engages in the provision of prenatal testing, precision oncology, and pathogenic detection services. The company was founded on October 26, 2021 and is headquartered in Hong Kong.

UGenix Biotech Ltd. is a holding company, which engages in the provision of prenatal testing, precision oncology, and pathogenic detection services. The company was founded on October 26, 2021 and is headquartered in Hong Kong.

UGenix Biotech Ltd. is a holding company, which engages in the provision of prenatal testing, precision oncology, and pathogenic detection services. The company was founded on October 26, 2021 and is headquartered in Hong Kong.

UGenix Biotech Ltd. is a holding company, which engages in the provision of prenatal testing, precision oncology, and pathogenic detection services. The company was founded on October 26, 2021 and is headquartered in Hong Kong.

UGenix Biotech Ltd. is a holding company, which engages in the provision of prenatal testing, precision oncology, and pathogenic detection services. The company was founded on October 26, 2021 and is headquartered in Hong Kong.

Beijing Saimo Technology Co., Ltd. engages in the design, research, and development of ICV Simulation testing products; and in the provision of related testing, validation, and evaluation solutions. Its business activities include testing, evaluation, and verification of the functionality, compatibility, safety, reliability, and comfortability of autonomous driving vehicles in the China. The company was founded on January 24, 2014 and is headquartered in Beijing, China.

UGenix Biotech Ltd. is a holding company, which engages in the provision of prenatal testing, precision oncology, and pathogenic detection services. The company was founded on October 26, 2021 and is headquartered in Hong Kong.

UGenix Biotech Ltd. is a holding company, which engages in the provision of prenatal testing, precision oncology, and pathogenic detection services. The company was founded on October 26, 2021 and is headquartered in Hong Kong.

Beijing Saimo Technology Co., Ltd. engages in the design, research, and development of ICV Simulation testing products; and in the provision of related testing, validation, and evaluation solutions. Its business activities include testing, evaluation, and verification of the functionality, compatibility, safety, reliability, and comfortability of autonomous driving vehicles in the China. The company was founded on January 24, 2014 and is headquartered in Beijing, China.

Beijing Saimo Technology Co., Ltd. engages in the design, research, and development of ICV Simulation testing products; and in the provision of related testing, validation, and evaluation solutions. Its business activities include testing, evaluation, and verification of the functionality, compatibility, safety, reliability, and comfortability of autonomous driving vehicles in the China. The company was founded on January 24, 2014 and is headquartered in Beijing, China.

Beijing Saimo Technology Co., Ltd. engages in the design, research, and development of ICV Simulation testing products; and in the provision of related testing, validation, and evaluation solutions. Its business activities include testing, evaluation, and verification of the functionality, compatibility, safety, reliability, and comfortability of autonomous driving vehicles in the China. The company was founded on January 24, 2014 and is headquartered in Beijing, China.

Beijing Saimo Technology Co., Ltd. engages in the design, research, and development of ICV Simulation testing products; and in the provision of related testing, validation, and evaluation solutions. Its business activities include testing, evaluation, and verification of the functionality, compatibility, safety, reliability, and comfortability of autonomous driving vehicles in the China. The company was founded on January 24, 2014 and is headquartered in Beijing, China.

Beijing Saimo Technology Co., Ltd. engages in the design, research, and development of ICV Simulation testing products; and in the provision of related testing, validation, and evaluation solutions. Its business activities include testing, evaluation, and verification of the functionality, compatibility, safety, reliability, and comfortability of autonomous driving vehicles in the China. The company was founded on January 24, 2014 and is headquartered in Beijing, China.

Beijing Saimo Technology Co., Ltd. engages in the design, research, and development of ICV Simulation testing products; and in the provision of related testing, validation, and evaluation solutions. Its business activities include testing, evaluation, and verification of the functionality, compatibility, safety, reliability, and comfortability of autonomous driving vehicles in the China. The company was founded on January 24, 2014 and is headquartered in Beijing, China.

Beijing Saimo Technology Co., Ltd. engages in the design, research, and development of ICV Simulation testing products; and in the provision of related testing, validation, and evaluation solutions. Its business activities include testing, evaluation, and verification of the functionality, compatibility, safety, reliability, and comfortability of autonomous driving vehicles in the China. The company was founded on January 24, 2014 and is headquartered in Beijing, China.

UGenix Biotech Ltd. is a holding company, which engages in the provision of prenatal testing, precision oncology, and pathogenic detection services. The company was founded on October 26, 2021 and is headquartered in Hong Kong.

UGenix Biotech Ltd. is a holding company, which engages in the provision of prenatal testing, precision oncology, and pathogenic detection services. The company was founded on October 26, 2021 and is headquartered in Hong Kong.